Abstract |
Recombinant human platelet-derived growth factor-BB ( rhPDGF-BB) promotes soft tissue and bone healing, and is Food and Drug Administration-approved for treatment of diabetic ulcers and periodontal defects. The short half-life of topical rhPDGF-BB protein application necessitates bolus, high-dose delivery. Gene therapy enables sustained local growth factor production. A novel gene activated matrix delivering polyplexes of polyethylenimine (PEI)-plasmid DNA encoding PDGF was evaluated for promotion of periodontal wound repair in vivo. PEI-pPDGF-B polyplexes were tested in human periodontal ligament fibroblasts and human gingival fibroblasts for cell viability and transfection efficiency. Collagen scaffolds containing PEI-pPDGF-B polyplexes at two doses, rhPDGF-BB, PEI vector or collagen alone were randomly delivered to experimentally induced tooth-supporting periodontal defects in a rodent model. Mandibulae were collected at 21 days for histologic observation and histomorphometry. PEI-pPDGF-B polyplexes were biocompatible to cells tested and enzyme-linked immunosorbent assay confirmed the functionality of transfection. Significantly greater osteogenesis was observed for collagen alone and rhPDGF-BB versus the PEI-containing groups. Defects treated with sustained PDGF gene delivery demonstrated delayed healing coupled with sustained inflammatory cell infiltrates lateral to the osseous defects. Continuous PDGF-BB production by nonviral gene therapy could have delayed bone healing. This nonviral gene delivery system in this model appeared to prolong inflammatory response, slowing alveolar bone regeneration in vivo.
|
Authors | A B Plonka, B Khorsand, N Yu, J V Sugai, A K Salem, W V Giannobile, S Elangovan |
Journal | Gene therapy
(Gene Ther)
Vol. 24
Issue 1
Pg. 31-39
(01 2017)
ISSN: 1476-5462 [Electronic] England |
PMID | 27824330
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biocompatible Materials
- Platelet-Derived Growth Factor
- Recombinant Proteins
- Polyethyleneimine
|
Topics |
- Animals
- Biocompatible Materials
(adverse effects)
- Bone Regeneration
- Fibroblasts
(drug effects, metabolism, physiology)
- Gene Transfer Techniques
(adverse effects)
- Humans
- Osteogenesis
- Periodontal Diseases
(therapy)
- Platelet-Derived Growth Factor
(genetics, metabolism)
- Polyethyleneimine
(adverse effects)
- Rats
- Rats, Sprague-Dawley
- Recombinant Proteins
(genetics, metabolism)
|